Neural Plasticity

Neural Plasticity / 2007 / Article
Special Issue

Plasticity and Anxiety

View this Special Issue

Research Article | Open Access

Volume 2007 |Article ID 079102 | https://doi.org/10.1155/2007/79102

Gabor Legradi, Mahasweta Das, Brian Giunta, Khemraj Hirani, E. Alice Mitchell, David M. Diamond, "Microinfusion of Pituitary Adenylate Cyclase-Activating Polypeptide into the Central Nucleus of Amygdala of the Rat Produces a Shift from an Active to Passive Mode of Coping in the Shock-Probe Fear/Defensive Burying Test", Neural Plasticity, vol. 2007, Article ID 079102, 12 pages, 2007. https://doi.org/10.1155/2007/79102

Microinfusion of Pituitary Adenylate Cyclase-Activating Polypeptide into the Central Nucleus of Amygdala of the Rat Produces a Shift from an Active to Passive Mode of Coping in the Shock-Probe Fear/Defensive Burying Test

Academic Editor: Georges Chapouthier
Received02 Feb 2007
Accepted18 Mar 2007
Published14 Jun 2007

Abstract

High concentrations of pituitary adenylate cyclase-activating polypeptide (PACAP) nerve fibers are present in the central nucleus of amygdala (CeA), a brain region implicated in the control of fear-related behavior. This study evaluated PACAPergic modulation of fear responses at the CeA in male Sprague-Dawley rats. PACAP (50–100   pmol) microinfusion via intra-CeA cannulae produced increases in immobility and time the rats spent withdrawn into a corner opposite to the electrified probe compared to controls in the shock-probe fear/defensive burying test. Shock-probe burying and exploration, numbers of shocks received, locomotion distance, and velocity were all reduced by intra-CeA PACAP injection. Further, intra-CeA PACAP effects were manifested only when the animals were challenged by shock, as intra-CeA PACAP injections did not cause significant changes in the behaviors of unshocked rats. Thus, intra-CeA administration of PACAP produces a distinct reorganization of stress-coping behaviors from active (burying) to passive modes, such as withdrawal and immobility. These findings are potentially significant toward enhancing our understanding of the involvement of PACAP and the CeA in the neural basis of fear and anxiety.

References

  1. A. Arimura and S. Shioda, “Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction,” Frontiers in Neuroendocrinology, vol. 16, no. 1, pp. 53–88, 1995. View at: Publisher Site | Google Scholar
  2. J. E. Morley, M. Horowitz, P. M. K. Morley, and J. F. Flood, “Pituitary adenylate cyclase activating polypeptide (PACAP) reduces food intake in mice,” Peptides, vol. 13, no. 6, pp. 1133–1135, 1992. View at: Publisher Site | Google Scholar
  3. W. T. Chance, H. Thompson, I. Thomas, and J. E. Fischer, “Anorectic and neurochemical effects of pituitary adenylate cyclase activating polypeptide in rats,” Peptides, vol. 16, no. 8, pp. 1511–1516, 1995. View at: Publisher Site | Google Scholar
  4. T. Murase, K. Kondo, K. Otake, and Y. Oiso, “Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats,” Neuroendocrinology, vol. 57, no. 6, pp. 1092–1096, 1993. View at: Google Scholar
  5. M. Nomura, Y. Ueta, R. Serino, Y. Yamamoto, I. Shibuya, and H. Yamashita, “Effects of centrally administered pituitary adenylate cyclase-activating polypeptide on c-fos gene expression and heteronuclear RNA for vasopressin in rat paraventricular and supraoptic nuclei,” Neuroendocrinology, vol. 69, no. 3, pp. 167–180, 1999. View at: Publisher Site | Google Scholar
  6. V. Grinevich, A. Fournier, and G. Pelletier, “Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus,” Brain Research, vol. 773, no. 1-2, pp. 190–196, 1997. View at: Publisher Site | Google Scholar
  7. G. Legradi, J. Hannibal, and R. M. Lechan, “Pituitary adenylate cyclase-activating polypeptide-nerve terminals densely innervate corticotropin-releasing hormone-neurons in the hypothalamic paraventricular nucleus of the rat,” Neuroscience Letters, vol. 246, no. 3, pp. 145–148, 1998. View at: Publisher Site | Google Scholar
  8. A. Agarwal, L. M. Halvorson, and G. Legradi, “Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene,” Molecular Brain Research, vol. 138, no. 1, pp. 45–57, 2005. View at: Publisher Site | Google Scholar
  9. S. D. Norrholm, M. Das, and G. Legradi, “Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN),” Regulatory Peptides, vol. 128, no. 1, pp. 33–41, 2005. View at: Publisher Site | Google Scholar
  10. A. M. M. Van Erp, M. R. Kruk, D. C. Willekens-Bramer et al., “Grooming induced by intrahypothalamic injection of ACTH in the rat: comparison with grooming induced by intrahypothalamic electrical stimulation and i.c.v. injection of ACTH,” Brain Research, vol. 538, no. 2, pp. 203–210, 1991. View at: Publisher Site | Google Scholar
  11. H. Monnikes, I. Heymann-Monnikes, and Y. Tache, “CRF in the paraventricular nucleus of the hypothalamus induces dose-related behavioral profile in rats,” Brain Research, vol. 574, no. 1-2, pp. 70–76, 1992. View at: Publisher Site | Google Scholar
  12. G. Telegdy and K. Kokavszky, “The action of pituitary adenylate cyclase activating polypeptide (PACAP) on passive avoidance learning. The role of transmitters,” Brain Research, vol. 874, no. 2, pp. 194–199, 2000. View at: Publisher Site | Google Scholar
  13. S. Maren, “Neurobiology of Pavlovian fear conditioning,” Annual Review of Neuroscience, vol. 24, pp. 897–931, 2001. View at: Publisher Site | Google Scholar
  14. M. Davis, “Neural circuitry of anxiety and stress disorders,” in Neuropsychopharmacology: The Fifth Generation of Progress, K. L. Davis, D. Charney, J. T. Coyle, and C. Nemeroff, Eds., pp. 931–951, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2002. View at: Google Scholar
  15. J. E. LeDoux, “The emotional brain, fear, and the amygdala,” Cellular and Molecular Neurobiology, vol. 23, no. 4-5, pp. 727–738, 2003. View at: Publisher Site | Google Scholar
  16. J. E. LeDoux, “Emotion circuits in the brain,” Annual Review of Neuroscience, vol. 23, pp. 155–184, 2000. View at: Publisher Site | Google Scholar
  17. K. Koves, A. Arimura, T. G. Gorcs, and A. Somogyvari-Vigh, “Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain,” Neuroendocrinology, vol. 54, no. 2, pp. 159–169, 1991. View at: Google Scholar
  18. L. Kivipelto, A. Absood, A. Arimura, F. Sundler, R. Hakanson, and P. Panula, “The distribution of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity is distinct from helodermin- and helospectin-like immunoreactivities in the rat brain,” Journal of Chemical Neuroanatomy, vol. 5, no. 1, pp. 85–94, 1992. View at: Publisher Site | Google Scholar
  19. H. D. Piggins, J. A. Stamp, J. Burns, B. Rusak, and K. Semba, “Distribution of pituitary adenylate cyclase activating polypeptide (PACAP) immunoreactivity in the hypothalamus and extended amygdala of the rat,” Journal of Comparative Neurology, vol. 376, no. 2, pp. 278–294, 1996. View at: Publisher Site | Google Scholar
  20. T. Kozicz, S. Vigh, and A. Arimura, “Axon terminals containing PACAP- and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat,” Brain Research, vol. 767, no. 1, pp. 109–119, 1997. View at: Publisher Site | Google Scholar
  21. J. Hannibal, “Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study,” Journal of Comparative Neurology, vol. 453, no. 4, pp. 389–417, 2002. View at: Publisher Site | Google Scholar
  22. H. Hashimoto, H. Nogi, K. Mori et al., “Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study,” Journal of Comparative Neurology, vol. 371, no. 4, pp. 567–577, 1996. View at: Publisher Site | Google Scholar
  23. D. Treit and J. P. Pinel, “Defensive burying,” in The Behavior of the Laboratory Rat, I. Q. Whishaw and B. Kolb, Eds., pp. 353–362, Oxford University Press, New York, NY, USA, 2005. View at: Google Scholar
  24. B. Roozendaal, J. M. Koolhaas, and B. Bohus, “Posttraining norepinephrine infusion into the central amygdala differentially enhances later retention in Roman high-avoidance and low- avoidance rats,” Behavioral Neuroscience, vol. 107, no. 4, pp. 575–579, 1993. View at: Publisher Site | Google Scholar
  25. D. Treit, C. Pesold, and S. Rotzinger, “Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety,” Behavioral Neuroscience, vol. 107, no. 5, pp. 770–785, 1993. View at: Publisher Site | Google Scholar
  26. A. Degroot, S. Kashluba, and D. Treit, “Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests,” Pharmacology Biochemistry and Behavior, vol. 69, no. 3-4, pp. 391–399, 2001. View at: Publisher Site | Google Scholar
  27. S. F. De Boer and J. M. Koolhaas, “Defensive burying in rodents: ethology, neurobiology and psychopharmacology,” European Journal of Pharmacology, vol. 463, no. 1–3, pp. 145–161, 2003. View at: Publisher Site | Google Scholar
  28. J. P. Huston, S. Schildein, P. Gerhardt, C. Privou, H. Fink, and R. U. Hasenöhrl, “Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s,” Peptides, vol. 19, no. 1, pp. 27–37, 1998. View at: Publisher Site | Google Scholar
  29. K. B. Baker and J. J. Kim, “Amygdalar lateralization in fear conditioning: evidence for greater involvement of the right amygdala,” Behavioral Neuroscience, vol. 118, no. 1, pp. 15–23, 2004. View at: Publisher Site | Google Scholar
  30. C. Pesold and D. Treit, “Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests,” Physiology and Behavior, vol. 52, no. 1, pp. 37–47, 1992. View at: Publisher Site | Google Scholar
  31. A. Arimura, “Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems,” Japanese Journal of Physiology, vol. 48, no. 5, pp. 301–331, 1998. View at: Publisher Site | Google Scholar
  32. D. Vaudry, B. J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry, “Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions,” Pharmacological Reviews, vol. 52, no. 2, pp. 269–324, 2000. View at: Google Scholar
  33. D. Treit and M. Fundytus, “A comparison of buspirone and chloridazepoxide in the shock-probe/burying test for anxiolytics,” Pharmacology Biochemistry and Behavior, vol. 30, no. 4, pp. 1071–1075, 1988. View at: Publisher Site | Google Scholar
  34. M. D. Cassell, L. J. Freedman, and C. Shi, “The intrinsic organization of the central extended amygdala,” Annals of the New York Academy of Sciences, vol. 877, no. 1, pp. 217–241, 1999. View at: Publisher Site | Google Scholar
  35. D. A. Hopkins and G. Holstege, “Amygdaloid projections to the mesencephalon, pons and medulla oblongata in the cat,” Experimental Brain Research, vol. 32, no. 4, pp. 529–547, 1978. View at: Publisher Site | Google Scholar
  36. J. E. LeDoux, J. Iwata, P. Cicchetti, and D. J. Reis, “Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear,” The Journal of Neuroscience, vol. 8, no. 7, pp. 2517–2529, 1988. View at: Google Scholar
  37. J. M. Hitchcock, C. B. Sananes, and M. Davis, “Sensitization of the startle reflex by footshock: blockade by lesions of the central nucleus of the amygdala or its efferent pathway to the brainstem,” Behavioral Neuroscience, vol. 103, no. 3, pp. 509–518, 1989. View at: Publisher Site | Google Scholar
  38. S. Saha, T. F. C. Batten, and Z. Henderson, “A GABAergic projection from the central nucleus of the amygdala to the nucleus of the solitary tract: a combined anterograde tracing and electron microscopic immunohistochemical study,” Neuroscience, vol. 99, no. 4, pp. 613–626, 2000. View at: Publisher Site | Google Scholar
  39. P. J. Lang, M. Davis, and A. Öhman, “Fear and anxiety: animal models and human cognitive psychophysiology,” Journal of Affective Disorders, vol. 61, no. 3, pp. 137–159, 2000. View at: Publisher Site | Google Scholar
  40. B. Roozendaal, J. M. Koolhaas, and B. Bohus, “Central amygdala lesions affect behavioral and autonomic balance during stress in rats,” Physiology and Behavior, vol. 50, no. 4, pp. 777–781, 1991. View at: Publisher Site | Google Scholar
  41. B. Roozendaal, J. M. Koolhaas, and B. Bohus, “Attenuated cardiovascular, neuroendocrine, and behavioral responses after a single footshock in central amygdaloid lesioned male rats,” Physiology and Behavior, vol. 50, no. 4, pp. 771–775, 1991. View at: Publisher Site | Google Scholar
  42. B. Roozendaal, J. M. Koolhaas, and B. Bohus, “The role of the central amygdala in stress and adaption,” Acta Physiologica Scandinavica, Supplement, vol. 640, pp. 51–54, 1997. View at: Google Scholar
  43. M. R. Tinsley and M. S. Fanselow, “Fear,” in The Behavior of the Laboratory Rat, I. Q. Whishaw and B. Kolb, Eds., pp. 410–421, Oxford University Press, New York, NY, USA, 2005. View at: Google Scholar
  44. J. Hannibal, M. Møller, O. P. Ottersen, and J. Fahrenkrug, “PACAP and glutamate are co-stored in the retinohypothalamic tract,” Journal of Comparative Neurology, vol. 418, no. 2, pp. 147–155, 2000. View at: Publisher Site | Google Scholar
  45. G. Legradi, S. Shioda, and A. Arimura, “Pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in autonomic regulatory areas of the rat medulla oblongata,” Neuroscience Letters, vol. 176, no. 2, pp. 193–196, 1994. View at: Publisher Site | Google Scholar
  46. N. J. Dun, T. Miyazaki, H. Tang, and E. C. Dun, “Pituitary adenylate cyclase activating polypeptide immunoreactivity in the rat spinal cord and medulla: implication of sensory and autonomic functions,” Neuroscience, vol. 73, no. 3, pp. 677–686, 1996. View at: Publisher Site | Google Scholar
  47. G. Legradi, J. Hannibal, and R. M. Lechan, “Association between pituitary adenylate cyclase-activating polypeptide and thyrotropin-releasing hormone in the rat hypothalamus,” Journal of Chemical Neuroanatomy, vol. 13, no. 4, pp. 265–279, 1997. View at: Publisher Site | Google Scholar
  48. M. Das, C. S. Vihlen, and G. Legradi, “Hypothalamic and brainstem sources of pituitary adenylate cyclase-activating polypeptide nerve fibers innervating the hypothalamic paraventricular nucleus in the rat,” Journal of Comparative Neurology, vol. 500, no. 4, pp. 761–776, 2007. View at: Publisher Site | Google Scholar
  49. S. Makino, T. Shibasaki, N. Yamauchi et al., “Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat,” Brain Research, vol. 850, no. 1-2, pp. 136–143, 1999. View at: Publisher Site | Google Scholar
  50. M. Diamant, G. Croiset, and D. de Wied, “The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats,” Peptides, vol. 13, no. 6, pp. 1149–1158, 1992. View at: Publisher Site | Google Scholar
  51. A. H. Swiergiel, L. K. Takahashi, and N. H. Kalin, “Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat,” Brain Research, vol. 623, no. 2, pp. 229–234, 1993. View at: Publisher Site | Google Scholar
  52. J. E. Haddon and S. Killcross, “Prefrontal cortex lesions disrupt the contextual control of response conflict,” The Journal of Neuroscience, vol. 26, no. 11, pp. 2933–2940, 2006. View at: Publisher Site | Google Scholar
  53. G. J. Quirk, E. Likhtik, J. G. Pelletier, and D. Paré, “Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons,” The Journal of Neuroscience, vol. 23, no. 25, pp. 8800–8807, 2003. View at: Google Scholar
  54. A. A. Shah and D. Treit, “Excitotoxic lesions of the medial prefrontal cortex attenuate fear responses in the elevated-plus maze, social interaction and shock probe burying tests,” Brain Research, vol. 969, no. 1-2, pp. 183–194, 2003. View at: Publisher Site | Google Scholar
  55. A. A. Shah, T. Sjovold, and D. Treit, “Inactivation of the medial prefrontal cortex with the GABAA receptor agonist muscimol increases open-arm activity in the elevated plus-maze and attenuates shock-probe burying in rats,” Brain Research, vol. 1028, no. 1, pp. 112–115, 2004. View at: Publisher Site | Google Scholar

Copyright © 2007 Gabor Legradi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views197
Downloads695
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.